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Background
The small, diffusible molecule cAMP plays a key signalling
role in almost all organisms. In S. cerevisiae, cAMP is syn-
thesized by adenylate cyclase [1], and hydrolyzed by the
phosphodiesterases Pde1p and Pde2p [2,3]. The only
function of cAMP in yeast is to activate PKA (Protein
Kinase A). A molecule of PKA is a tetramer consisting of
two catalytic (C) and two regulatory (R) subunits. Cyclic
AMP binds to the R subunit, allowing its dissociation
from C, allowing C to become catalytically active. PKA is
believed to activate Pde1p [4], as well as indirectly inhibit
the activity of adenylate cyclase [5]. We have created two
mathematical models (one simplified and one detailed)
in order to better understand the mechanisms of PKA acti-
vation. We have also created a model to investigate the
complete cAMP pathway.
Results
The PKA models are able to behave appropriately when
the cAMP level is altered, giving an increased concentra-
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Species concentrations of the detailed PKA model under low (A) and high (B) cAMP concentrationFigure 1
Species concentrations of the detailed PKA model under low (A) and high (B) cAMP concentration. C: cAMP levels of model 
mutants. Glucose concentration is increased after five seconds.Page 1 of 2
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tion of free catalytic subunit (see Figure 1). In the wild
type complete pathway model a "spike" of cAMP is
observed after glucose addition. The cAMP level oscillates
before reaching a steady state. The spike has a higher peak
in the pde1Δ mutant (see Figure 1).
Conclusion
The models of PKA activation can reproduce events seen
in vivo, but the detailed model also allows for concentra-
tions of intermediates to be predicted. This could give
insights into the mechanism by which PKA activation is
regulated. The complete pathway model can reproduce
phosphodiesterase knockout mutant phenotypes seen in
vivo [4], as well as predicting that the cAMP level oscillates
before reaching a steady-state. Further analysis and devel-
opment of these models should give further insights into
the cAMP pathway in yeast.
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